The effect of methyldopa on the excretion of catecholamines in patients with extrapyramidal disorders.
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002395:Catecholamines / Q000652:urine*; D004295:Dihydroxyphenylalanine / Q000652:urine; D004298:Dopamine / Q000652:urine; D004837:Epinephrine / Q000652:urine; D006801:Humans; D008333:Mandelic Acids / Q000652:urine; D008750:Methyldopa / Q000494:pharmacology / Q000627:therapeutic use*; D009069:Movement Disorders / Q000188:drug therapy* / Q000652:urine; D009638:Norepinephrine / Q000652:urine; D010648:Phenylacetates / Q000652:urine
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002395:Catecholamines; D008333:Mandelic Acids; D010648:Phenylacetates; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine